The role of insulin analogs in type 2 diabetes in the rural community

References

• Centers for Disease Control and Prevention. National diabetes fact sheet: United States, 2005. Atlanta, GA, US Department of Health and Human Services, Centers for Disease Control and Prevention, 2005
   Google Scholar
• UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837-53
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial. Am J Cardiol 1995;75:894-903
   PubMed Web of Science ®Google Scholar
• Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-53
   PubMed Web of Science ®Google Scholar
• Saaddine JB, Engelgau MM, Beckles GL, et al. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med 2002;136:565-74
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2008. Diabetes Care 2008;31 (Suppl 1):12-54
   Google Scholar
• Leslie CA, Satin-Rapaport W, Matheson D, et al. Psychological insulin resistance: a missed diagnosis?. Diabetes Spectrum 1994;7:52-7
   Google Scholar
• UK Prospective Diabetes Study Group. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995;310:83-8.
   PubMed Web of Science ®Google Scholar
• Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: The National Academies Press, 2003.
   Google Scholar
• Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA 2002;288:475-82
   PubMed Web of Science ®Google Scholar
• Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ 2005;31:564-71
   PubMed Web of Science ®Google Scholar
• Dansky KH, Dirani R. The use of health care services by people with diabetes in rural areas. J Rural Health 1998;14:129-37
   PubMed Web of Science ®Google Scholar
• Strauss K, MacLean C, Troy A, et al. Driving distance as a barrier to glycemic control in diabetes. J Gen Intern Med 2006;21:378-80
   PubMed Web of Science ®Google Scholar
• Arcury TA, Skelly AH, Gesler WM, et al. Diabetes beliefs among low-income, white residents of a rural North Carolina community. J Rural Health 2005;21:337-45
   PubMed Web of Science ®Google Scholar
• Utz SW, Steeves RH, Wenzel J, et al. “Working hard with it”: self-management of type 2 diabetes by rural African Americans. Fam Community Health 2006;29:195-205
   PubMed Web of Science ®Google Scholar
• O'Brien T, Denham SA. Diabetes care and education in rural regions. Diabetes Educ 2008;34:334-47
   PubMed Web of Science ®Google Scholar
• Zoorob RJ, Mainous III AG . Practice patterns of rural family physicians based on the American Diabetes Association standards of care. J Community Health 1996;21:175-82
   PubMed Web of Science ®Google Scholar
• Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care 2002;25:2224-9
   PubMed Web of Science ®Google Scholar
• Mills RD, Schwartz F, Shubrook JH. Evaluation of diabetes management in a rural community hospital. Endocr Pract 2008;14:50-5
   PubMedGoogle Scholar
• Richert ML, Webb AJ, Morse NA, et al. Move more diabetes: using lay health educators to support physical activity in a community-based chronic disease self-management program. Diabetes Educ 2007;33:179-84S
   PubMed Web of Science ®Google Scholar
• Shaw BA, Gallant MP, Riley-Jacome M, et al. Assessing sources of support for diabetes self-care in urban and rural underserved communities. J Community Health 2006;31:393-412
   PubMed Web of Science ®Google Scholar
• Mainous AG, III, King DE, Garr DR, et al. Race, rural residence, and control of diabetes and hypertension. Ann Fam Med 2004;2:563-8
   PubMed Web of Science ®Google Scholar
• Arcury TA, Snively BM, Bell RA, et al. Physical activity among rural older adults with diabetes. J Rural Health 2006;22:164-8
   PubMed Web of Science ®Google Scholar
• Deshpande AD, Baker EA, Lovegreen SL, et al. Environmental correlates of physical activity among individuals with diabetes in the rural midwest. Diabetes Care 2005;28:1012-18
   PubMed Web of Science ®Google Scholar
• Bell RA, Arcury TA, Stafford JM, et al. Ethnic and sex differences in ownership of preventive health equipment among rural older adults with diabetes. J Rural Health 2007;23:332-8
   PubMed Web of Science ®Google Scholar
• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;16029:1963-72
   Google Scholar
• Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2008;31:173-5
   PubMed Web of Science ®Google Scholar
• Wright A, Burden ACF, Paisey RB, et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6
   PubMed Web of Science ®Google Scholar
• Schwartz S, Sievers R, Strange P, et al. Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis. Diabetes Care 2003;26:2238-43
   PubMed Web of Science ®Google Scholar
• Riddle MC. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin North Am 2005;34:77-98
   PubMed Web of Science ®Google Scholar
• Feinglos MN, Saad MF, Pi-Sunyer FX, et al. Effects of liraglutide (NN2211), a long-acting GLP-1 analogue, on glycaemic control and bodyweight in subjects with Type 2 diabetes. Diabet Med 2005;22:1016-23
   PubMed Web of Science ®Google Scholar
• Januvia [package insert]. Whitehouse Station, NJ: Merck & Co., Inc., 2007
   Google Scholar
• Ahren B, Gomis R, Standl E, et al. Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care 2004;27:2874-80
   PubMed Web of Science ®Google Scholar
• Gerstein HC, Yale J-F, Harris SB, et al. A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies with Insulin Glargine for Hyperglycaemia Treatment) Study. Diabet Med 2006;23:736-42
   PubMed Web of Science ®Google Scholar
• Riddle MC, Rosenstock J, Gerich J, Insulin Glargine 4002 Study Investigators. The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 2003;26:3080-6.
   PubMed Web of Science ®Google Scholar
• Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49:2142-8
   PubMed Web of Science ®Google Scholar
• Eliaschewitz FG, Calvo C, Valbuena H, et al. Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride. Arch Med Res 2006;37:495-501
   Google Scholar
• Yki-Järvinen H, Dressler A, Ziemen M. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. Diabetes Care 2000;23:1130-6
   PubMed Web of Science ®Google Scholar
• Massi Benedetti M, Humburg E, Dressler A, et al. A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes. Horm Metab Res 2003;35:189-96
   PubMed Web of Science ®Google Scholar
• Rosenstock J, Schwartz SL, Park GD, et al. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin. Diabetes Care 2001;24:631-6
   PubMed Web of Science ®Google Scholar
• Yki-Järvinen H, Kauppinen-Makelin R, Tiikkainen M, et al. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia 2006;49:442-51
   PubMed Web of Science ®Google Scholar
• Danne T, Lupke K, Walte K, et al. Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care 2003;26:3087-92
   PubMed Web of Science ®Google Scholar
• Hermansen K, Davies M, Derezinski T, et al. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes. Diabetes Care 2006;29:1269-74
   PubMed Web of Science ®Google Scholar
• Rašlová K, Bogoev M, Raz I, et al. Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004;66:193-201
   PubMed Web of Science ®Google Scholar
• Milicevic Z, Profozic V, Wyatt J, et al. Intramuscular injection of insulin lispro or soluble human insulin: pharmacokinetics and glucodynamics in type 2 diabetes. Diabet Med 2001;18:562-6
   PubMed Web of Science ®Google Scholar
• Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company, 2007
   Google Scholar
• Mudaliar SR, Lindberg FA, Joyce M, et al. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care 1999;22:1501-6
   PubMed Web of Science ®Google Scholar
• NovoLog [physician insert]. Princeton, NJ: Novo Nordisk, 2007
   Google Scholar
• Rave K, Klein O, Frick AD, et al. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes. Diabetes Care 2006;29:1812-7
   PubMed Web of Science ®Google Scholar
• Apidra [package insert]. Bridgewater, NJ: sanofi-aventis US, 2007
   Google Scholar
• Leahy JL. Intensive insulin therapy in type 1 diabetes mellitus. In: Leahy, JL, Cefalu WT, eds. Insulin Therapy, New York, NY: Marcel Dekker, 2002:87-112
   Google Scholar
• Flood TM. Appropriate use of insulin analogs in an increasingly complex type 2 diabetes mellitus (T2DM) landscape. J Fam Pract 2007;56:S1-S12
   PubMedGoogle Scholar
• Lantus [package insert]. Bridgewater, NJ: Sanofi-aventis US, 2007
   Google Scholar
• Yokoyama H, Tada J, Kamikawa F, et al. Efficacy of conversion from bedtime NPH insulin to morning insulin glargine in type 2 diabetic patients on basal-prandial insulin therapy. Diabetes Res Clin Pract 2006;73:35-40
   PubMed Web of Science ®Google Scholar
• Levemir [package insert]. Princeton, NJ: Novo Nordisk, 2005
   Google Scholar
• Wittlin SD, Woehrle HJ, Gerich JE. Insulin pharmacokinetics. In: Leahy JL, Cefalu WT, eds. Insulin Therapy. New York, NY: Marcel Dekker, 2002:73-85
   Google Scholar
• Jungmann E. Preprandial vs. postprandial injections of insulin glusine in intensified insulin therapy of obese patients with type 2 diabetes mellitus. Presented at: 66th Scientific Sessions of the American Diabetes Association; June 9–13, 2006; Washington, DC. Abstract 495-P
   Google Scholar
• Luzio S, Peter R, Dunseath GJ, et al. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period. Diabetes Res Clin Pract 2008;79:269-75
   PubMed Web of Science ®Google Scholar
• Chlup R, Zapletalova J, Seckar P, et al. Benefits of complementary therapy with insulin aspart versus human regular insulin in persons with type 2 diabetes mellitus. Diabetes Technol Ther 2007;9:223-31
   PubMed Web of Science ®Google Scholar
• Exubera [package insert]. New York, NY: Pfizer Inc, 2006
   Google Scholar
• Janka HU, Plewe G, Riddle MC, et al. Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 2005;28:254-9
   PubMed Web of Science ®Google Scholar
• Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28:260-5
   PubMed Web of Science ®Google Scholar
• Davies M, Storms F, Shutler S, et al. Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005;28:1282-8
   PubMed Web of Science ®Google Scholar
• Kennedy L, Herman WH, Strange P, et al. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1C on glycemic control in patients with type 2 diabetes: The Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006;29:1-8
   PubMed Web of Science ®Google Scholar
• Bergenstal RM, Johnson M, Powers MA, et al. Adjust to target in type 2 diabetes: comparison of a simple algorithm to carbohydrate counting for adjustment of mealtime insulin glulisine. Diabetes Care 2008;35:1305-10
   Google Scholar
• Brody GH, Kogan SM, Murry VM, et al. Psychological functioning, support for self-management, and glycemic control among rural African American adults with diabetes mellitus type 2. Health Psychol 2008;27:S83-90
   Google Scholar
• Butcher MK, Gilman J, Meszaros JF, et al. Improving access to quality diabetes education in a rural state: the Montana quality diabetes education initiative. Diabetes Educ 2006;32:963-7
   PubMed Web of Science ®Google Scholar
• Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:149-59
   PubMedGoogle Scholar
• Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003;43:173-84
   PubMedGoogle Scholar
• Rothman R, Malone R, Bryant B, et al. The relationship between literacy and glycemic control in a diabetes disease-management program. Diabetes Educ 2004;30:263-73
   PubMed Web of Science ®Google Scholar
• Rothman RL, Dewalt DA, Malone R, et al. Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA 2004;292:1711-16
   PubMed Web of Science ®Google Scholar
• Bray P, Thompson D, Wynn JD, et al. Confronting disparities in diabetes care: the clinical effectiveness of redesigning care management for minority patients in rural primary care practices. J Rural Health 2005;21:317-21
   PubMed Web of Science ®Google Scholar
• Bray P, Roupe M, Young S, et al. Feasibility and effectiveness of system redesign for diabetes care management in rural areas: the eastern North Carolina experience. Diabetes Educ 2005;31:712-18
   PubMed Web of Science ®Google Scholar
• Dettori N, Flook BN, Pessl E, et al. Improvements in care and reduced self-management barriers among rural patients with diabetes. J Rural Health 2005;21:172-7
   PubMed Web of Science ®Google Scholar
• Johnson EA, Webb WL, McDowall JM, et al. A field-based approach to support improved diabetes care in rural states. Prev Chronic Dis 2005;2:A08
   Google Scholar
• Haase R, Russell S. Improving diabetes care and outcomes in a rural primary care clinic. Jt Comm J Qual Patient Saf 2006;32:246-52
   PubMedGoogle Scholar
• Tudiver F, Wolff LT, Morin PC, et al. Primary care providers' perceptions of home diabetes telemedicine care in the IDEATel project. J Rural Health 2007;23:55-61
   PubMed Web of Science ®Google Scholar
• Sarkar U, Handley MA, Gupta R, et al. Use of an interactive, telephone-based self-management support program to identify adverse events among ambulatory diabetes patients. J Gen Intern Med 2008;23:459-65
   PubMed Web of Science ®Google Scholar